Physician profile
David L Webb
NPI 1588879845
$3,915.01
in general payments reported to CMS, 2019-2025
22 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,913 · 2020: $311 · 2021: $33.25 · 2022: $38.60 · 2023: $176 · 2024: $253 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898 · Travel and Lodging: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.25 |
| Travel and Lodging | $720.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,056.42 | 2019-2025 | |
| Medical Device Business Services, INC. | $799.61 | 2019 | |
| Ethicon US, LLC | $388.43 | 2019-2024 | Echelon Circular |
| Davol INC. | $304.91 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Asensus Surgical, INC. | $260.01 | 2019 | |
| Covidien LP | $216.93 | 2019 | |
| Kci USA, INC. | $141.61 | 2019 | |
| Baxter Healthcare | $123.74 | 2019-2021 | |
| Dilon Technologies, INC. | $110.59 | 2025 | Hemoblast Bellows |
| W. L. Gore & Associates, INC. | $92.00 | 2025 | Gore Synecor Biomaterial |
| Mallinckrodt Enterprises LLC | $71.95 | 2019 | |
| Boston Scientific Corporation | $60.40 | 2019-2020 | |
| Solventum Corporation | $57.71 | 2024 | Abthera Advance, V.A.C. Veraflo Cleanse Choice, Prevena |
| Avanos Medical | $49.18 | 2019 | |
| Medtronic, INC. | $40.06 | 2023 | Sonicision |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $38.03 | 2019-2024 | Ovitex 2s |
| Z-Medica, LLC | $22.55 | 2019 | |
| Sanara Medtech INC. | $20.55 | 2025 | Celleraterx |
| Misonix INC | $18.18 | 2019 | |
| Osiris Therapeutics INC. | $16.23 | 2019 | |
| Innocoll Pharmaceuticals Limited | $13.22 | 2022 | |
| Kerecis Limited | $12.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.